drugset / Trial / NCT01204164
Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a multicenter, open-label, dose escalation Phase 1 study.
Timeline
- Start
- 2010-08
- Primary completion
- 2016-03
- Completion
- 2016-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carfilzomib | Other / unclassified | — | — |
| Subject | Zotiraciclib | Small molecule | — | Oral |
| Background | Dexamethasone | Small molecule | — | Oral |